Cervical cancer is one of the most preventable forms of cancer, yet thousands of women across the UK are diagnosed with it every year. The key to prevention lies in early detection of the human papillomavirus (HPV), the virus responsible for almost all cervical cancers.

Recent changes to the NHS Cervical Screening Programme mean that some people who have previously not attended cervical screening appointments are now being offered HPV self-testing kits at home, marking a significant step forward in improving access to this potentially life-saving service.

While HPV self-testing kits have the potential to encourage more people to participate in screening, it is important to understand that they are designed to complement, rather than replace, cervical screening (previously known as a smear test). Both have an important role to play in the fight against cervical cancer.

What is HPV?

HPV is a very common virus. Most people will come into contact with it at some point in their lives, and in the majority of cases it causes no problems and clears naturally. However, some high-risk strains of HPV can cause changes to the cells of the cervix over time, which may eventually develop into cervical cancer, if left untreated.

This is why cervical screening now focuses primarily on testing for HPV. Detecting high-risk HPV early allows healthcare professionals to monitor or treat abnormal cell changes before cancer develops.

The Introduction of HPV self-testing kits

In England, the NHS has begun rolling out HPV self-testing kits to eligible individuals who have not attended cervical screening despite previous invitations. The first phase will focus on those aged between 30-65 years old.

The kit contains a simple swab that is used to collect a vaginal sample at home, which is then returned to a laboratory for testing for high-risk HPV.

The initiative was introduced in response to declining cervical screening attendance rates and aims to remove some of the barriers that prevent people from accessing screening. Research has shown that factors such as embarrassment, discomfort, cultural sensitivities, previous traumatic experiences, childcare responsibilities and difficulty finding time for appointments can all contribute to low uptake.

For many, being able to complete the test in private, at a time that suits them, may make the difference between participating in screening and missing out altogether.

Why self-testing could save lives

One of the most promising aspects of HPV self-testing is its potential to reach people who have previously fallen through the gaps. Millions of people in England are overdue for cervical screening, leaving them at risk of undetected HPV infection and cervical cancer.

Home testing offers greater convenience and autonomy. For individuals who feel anxious about such examinations or who struggle to attend appointments due to work, caring responsibilities or disability, self-testing provides an alternative route into the screening programme.

By increasing participation, and detecting HPV before cell changes become cancerous, it gives healthcare professionals the opportunity to intervene and prevent cancer from developing in the first place.

Why cervical screening still remains crucial

Although self-testing is an exciting development, it is important not to view it as a replacement for cervical screening.

A self-test can identify the presence of high-risk HPV, but it cannot check for abnormal cervical cells. If HPV is detected in a home test, the individual will still need to attend a follow-up cervical screening appointment, where a healthcare professional will take a sample directly from the cervix to determine whether any cell changes are present.

Cervical screening therefore remains the most comprehensive method of assessing cervical health. It allows clinicians to investigate potential problems further and ensure that any abnormal cell changes are monitored or treated appropriately.

Taking up the invitation for cervical screening remains one of the most effective ways to protect against cervical cancer.

The importance of screening

Whether you are offered an HPV self-testing kit or invited to attend a cervical screening appointment, acting on that invitation is one of the most important things you can do for your health.

Cervical screening is not a test for cancer itself. Rather, it is designed to identify the warning signs before cancer develops. In many cases, treatment of abnormal cell changes can prevent cervical cancer altogether.

Unfortunately, cervical cancer can sometimes be diagnosed at a later stage when people delay or miss screening opportunities. Improving participation in screening programmes is therefore a vital part of ongoing efforts to reduce cervical cancer rates and improve outcomes for patients.

Making cervical screening more accessible

The introduction of HPV self-testing kits represents a significant and welcome development in cervical cancer prevention. By making screening more accessible, the NHS hopes to encourage more people to participate in a programme that has the potential to save lives.

However, the success of the initiative will ultimately depend on people taking up the opportunity, whether through a self-testing kit or a screening appointment. Both approaches share the same goal: identifying high-risk HPV and preventing cervical cancer before it has the chance to develop.

It is also important to see your GP urgently if you notice any unusual vaginal bleeding, unpleasant discharge, pain during sex or pain in your pelvis or lower back. Do not wait until you receive your invitation for HPV self-testing kits or cervical screening appointment to discuss these symptoms.

Patients are entitled to expect accurate testing, prompt communication and appropriate follow-up when concerns are identified. Where failures in care have contributed to a delayed cervical cancer diagnosis, it may be appropriate to seek legal advice to understand what happened and whether the care provided met acceptable standards.